$RDZNW

Roadzen Inc.

CIK:0001868640|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 16,194,324	$ 10,865,545
Costs and expenses:
Cost of services	6,923,789	4,469,453
Research and development	419,115	81,534
Sales and marketing	7,206,127	6,132,010
General and administrative	2,458,724	2,577,897
Depreciation and amortization	729,516	125,000
Total costs and expenses	17,737,272	13,385,894
Loss from operations	(1,542,948)	(2,520,348)
Interest expense (net)	(2,854,699)	(941,319)
Fair value gains/(losses) in financial instruments carried at fair value	(7,210,865)	(511,538)
Other income (net)	1,837,757	(47,922)
Total other income/(expense)	(8,227,807)	(1,500,779)
(Loss)/Income before income tax expense	(9,770,755)	(4,021,128)
Less: income tax (benefit)/expense	(6,620)	79,979
Net (loss)/income before non-controlling interest	(9,764,135)	(4,101,107)
Net loss attributable to non-controlling interest, net of tax	30,240	(95,337)
Net Loss attributable to Ordinary shareholders	$ (9,794,375)	$ (4,005,770)
Net loss per share attributable to Ordinary shareholders
Basic	$ (0.12)	$ (0.05)
Diluted	$ (0.12)	$ (0.05)
Weighted-average number of shares used in computing net loss per share - Basic	82,718,614	74,290,986
Weighted-average number of shares used in computing net loss per share - Diluted	82,718,614	74,290,986

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Mar. 31, 2026
Cash flows from operating activities
Net loss per share attributable to Ordinary shareholders	$ (9,794,375)	$ (4,005,770)	$ (22,516,222)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	729,516	125,000
Stock based compensation	75,376	71,358
Deferred income taxes	(16,118)	(1,289)
Unrealized foreign exchange loss/(profit)	109,427	(9,456)
Expenses settled through issuance of equity shares	812,288
Fair value losses in financial instruments carried at fair value	7,210,865	511,538
Expected credit loss (net of reversal)	(1,540,122)	198,749
Balances written Off/(back)	(1,793,721)
Net loss attributable to non-controlling interest, net of tax	30,240	(95,337)
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:
Inventories	(72,073)	103,415
Accounts receivables, net	159,750	(147,930)
Prepayments and other assets	(2,082,810)	(2,071,466)
Accounts payable and accrued expenses	245,637	2,323,205
Other liabilities	452,958	76,478
Net cash used in operating activities	(5,473,162)	(2,921,507)
Cash flows from investing activities
Purchase of property and equipment, intangible assets and goodwill	(464,491)	(274,056)
Consideration paid for business acquired in prior year	(925,000)
Investment in mutual funds and bonds	(1,515)
Proceeds from sale of mutual fund		73,116
Net cash used in investing activities	(1,391,006)	(200,940)
Cash flows from financing activities
Proceeds from issue of ordinary shares	7,460,000	1,386,959
Net proceeds/(payments) from short-term borrowings	(1,175,305)	49,990
Net cash generated from financing activities	6,284,695	1,436,949
Effect of exchange rate changes on cash and cash equivalents		(24,586)
Net (decrease)/increase in cash and cash equivalents (including restricted cash)	(579,473)	(1,710,084)
Cash and cash equivalents at the beginning of the period (including restricted cash)	6,800,620	5,053,654	5,053,654
Total cash and cash equivalents	6,221,147	3,343,570	6,800,620
Reconciliation of cash and cash equivalents
Cash and cash equivalents	6,004,085	3,124,856	6,578,594
Restricted cash	217,062	218,714	$ 222,026
Supplemental disclosure of cash flow information
Cash paid for interest, net of amounts capitalized	1,821,711	1,001,397
Non-cash investing and financing activities
Consideration payable in connection with acquisitions	1,074,070	8,376,253
Interest accrued on borrowings	$ 4,941,475	$ 2,089,465

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Mar. 31, 2026
Current assets:
Cash and cash equivalents	$ 6,004,085	$ 6,578,594
Accounts receivable, net	6,938,995	7,500,439
Inventories	188,628	116,555
Prepayments and other current assets	13,133,834	17,833,119
Investments	231,509	229,994
Total current assets	26,497,051	32,258,701
Non current assets
Restricted cash	217,062	222,026
Non marketable securities
Property and equipment, net	569,551	536,997
Goodwill	7,621,604	7,616,973
Operating lease right-of-use assets	2,027,950	1,374,147
Intangible assets, net	9,749,705	9,651,915
Other long-term assets	1,037,748	997,802
Total Non current assets	21,223,620	20,399,860
Total assets	47,720,671	52,658,561
Current liabilities
Current portion of long-term borrowings	12,511,196	9,829,713
Short-term borrowings	6,782,103	7,843,267
Accounts payable and accrued expenses	29,105,363	30,245,947
Derivative warrant liabilities	2,422,645	1,987,003
Short-term operating lease liabilities	575,557	325,255
Other current liabilities	7,594,007	8,072,789
Total current liabilities	58,990,871	58,303,974
Non current liabilities
Long-term borrowings	13,706,433	15,612,108
Long-term operating lease liabilities	1,129,147	699,817
Other long-term liabilities	4,526,041	4,561,246
Total Non current liabilities	19,361,621	20,873,171
Total liabilities	78,352,492	79,177,145
Commitments and contingencies (refer note 21)
Shareholders’ Equity/(Deficit)
Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of June 30, 2026 and March 31, 2026; 84,598,480 and 79,695,672 shares outstanding as of June 30, 2026 and March 31, 2026, respectively	117,760,582	112,128,293
Accumulated deficit	(255,974,533)	(246,224,660)
Accumulated other comprehensive income/(loss)	(1,195,734)	(1,299,868)
Other components of equity	105,611,372	105,747,998
Total shareholders’ deficit	(33,798,313)	(29,648,237)
Non-controlling interest	3,166,492	3,129,653
Total deficit	(30,631,821)	(26,518,584)
Total liabilities and Total Deficit	$ 47,720,671	$ 52,658,561